Two Sigma Advisers’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-68,400
Closed -$767K 2611
2023
Q2
$767K Buy
68,400
+1,800
+3% +$16K ﹤0.01% 1642
2023
Q1
$699K Buy
+66,600
New +$734K ﹤0.01% 1801

Other funds holding ENFN

Two Sigma Advisers's ENFN Position: Q3 2023 in Review

Two Sigma Advisers sold out of Enfusion, Inc. (ENFN) in Q3 2023, closing a stake of 68,400 shares — an estimated $767K sold.

Two Sigma Advisers first reported a position in ENFN in Q1 2023 and held it in 2 quarters. The position peaked at $767K in Q2 2023. 75 funds tracked by Wall St. Rank hold ENFN as of Q3 2023.

  • Two Sigma Advisers reported no remaining Enfusion, Inc. position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 68,400 Enfusion, Inc. shares in Q3 2023, an estimated $767K.
  • Two Sigma Advisers first reported a position in Enfusion, Inc. in Q1 2023 and held it in 2 quarters.
  • Two Sigma Advisers's Enfusion, Inc. position peaked at $767K in Q2 2023.
  • 75 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.